These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 18820278)

  • 21. Effectiveness of antibiotics given to asymptomatic men for an increased prostate specific antigen.
    Baltaci S; Süer E; Haliloğlu AH; Gokce MI; Elhan AH; Bedük Y
    J Urol; 2009 Jan; 181(1):128-32. PubMed ID: 19012907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 15-year followup of a population based prostate cancer screening study.
    Kjellman A; Akre O; Norming U; Törnblom M; Gustafsson O
    J Urol; 2009 Apr; 181(4):1615-21; discussion 1621. PubMed ID: 19233435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-time elastography for the diagnosis of prostate cancer: evaluation of elastographic moving images.
    Miyagawa T; Tsutsumi M; Matsumura T; Kawazoe N; Ishikawa S; Shimokama T; Miyanaga N; Akaza H
    Jpn J Clin Oncol; 2009 Jun; 39(6):394-8. PubMed ID: 19359330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate-specific antigen-based screening for prostate cancer: evidence, controversies and future perspectives.
    Ito K
    Int J Urol; 2009 May; 16(5):458-64. PubMed ID: 19341365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of 6- and 12-core prostate biopsy in Taiwanese men: impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection.
    Chiang IN; Chang SJ; Pu YS; Huang KH; Yu HJ; Huang CY
    Urol Int; 2009; 82(3):270-5. PubMed ID: 19440012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defining increased future risk for prostate cancer: evidence from a population based screening cohort.
    Schröder FH; Roobol MJ; Andriole GL; Fleshner N
    J Urol; 2009 Jan; 181(1):69-74; discussion 74. PubMed ID: 19012915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-prostatic massage examination for prediction of asymptomatic prostatitis in needle biopsies: a prospective study.
    Tekin A; Yuksel A; Tekin S; Gumrukcu G; Aslan AR; Sengor F
    J Urol; 2009 Aug; 182(2):564-8; discussion 568-9. PubMed ID: 19524953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PSA after incidental irradiation of the nonmalignant prostate: long-term changes.
    Gripp S; Roos D; Rudoy M; Matuschek C; Hermsen D; Willers R; Budach W; Boelke E
    Strahlenther Onkol; 2008 Oct; 184(10):526-9. PubMed ID: 19016042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indications and timing for prostate biopsy, diagnosis of early stage prostate cancer and its definitive treatment: a clinical conundrum in the PSA era.
    Punnen S; Nam RK
    Surg Oncol; 2009 Sep; 18(3):192-9. PubMed ID: 19282170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rural residence and prostate cancer screening with prostate-specific antigen.
    Stamatiou K; Skolarikos A
    Rural Remote Health; 2009; 9(2):1227. PubMed ID: 19594290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A model of prostate-specific antigen screening outcomes for low- to high-risk men: information to support informed choices.
    Howard K; Barratt A; Mann GJ; Patel MI
    Arch Intern Med; 2009 Sep; 169(17):1603-10. PubMed ID: 19786680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostatic-specific antigen velocity after holmium laser enucleation of the prostate: possible predictor for the assessment of treatment effect durability for benign prostatic hyperplasia and detection of malignancy.
    Elmansy HM; Elzayat EA; Sampalis JS; Elhilali MM
    Urology; 2009 Nov; 74(5):1105-10. PubMed ID: 19773035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in prostate-specific antigen levels and prostate volume in octogenarian men: community-based study.
    Chung JS; Byun SS; Han BK; Jeong SJ; Hong SK; Lee SE
    Urology; 2009 Jun; 73(6):1270-3. PubMed ID: 19371943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Men older than 70 years have higher risk prostate cancer and poorer survival in the early and late prostate specific antigen eras.
    Sun L; Caire AA; Robertson CN; George DJ; Polascik TJ; Maloney KE; Walther PJ; Stackhouse DA; Lack BD; Albala DM; Moul JW
    J Urol; 2009 Nov; 182(5):2242-8. PubMed ID: 19758616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective evaluation of prostate cancer risk in candidates for inguinal hernia repair.
    Thomas AA; Rosenblatt S; Wachterman J; Liao W; Moussa A; Ponsky LE; Jones JS
    J Am Coll Surg; 2009 Sep; 209(3):371-6. PubMed ID: 19717042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multicenter evaluation of an investigational prostate cancer methylation assay.
    Baden J; Green G; Painter J; Curtin K; Markiewicz J; Jones J; Astacio T; Canning S; Quijano J; Guinto W; Leibovich BC; Nelson JB; Vargo J; Wang Y; Wuxiong C
    J Urol; 2009 Sep; 182(3):1186-93. PubMed ID: 19625061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis.
    Antunes AA; Leite KR; Sousa-Canavez JM; Camara-Lopes LH; Srougi M
    J Urol; 2009 Feb; 181(2):594-600. PubMed ID: 19084862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical recurrence after radical prostatectomy for prevalent versus incident cases of prostate cancer : implications for management.
    Nguyen PL; Chen MH; Catalona WJ; Alexander BM; Roehl KA; Loeb S; D'Amico AV
    Cancer; 2008 Dec; 113(11):3146-52. PubMed ID: 18932254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PSA testing in Austria: induced morbidity and saved mortality.
    Vutuc C; Waldhoer T; Lunglmayr G; Hoeltl W; Haidinger G
    Eur J Cancer Prev; 2009 Sep; 18(5):377-80. PubMed ID: 19512934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy.
    Pisters LL; Leibovici D; Blute M; Zincke H; Sebo TJ; Slezak JM; Izawa J; Ward JF; Scott SM; Madsen L; Spiess PE; Leibovich BC
    J Urol; 2009 Aug; 182(2):517-25; discussion 525-7. PubMed ID: 19524984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.